Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Field of Science
- 3.2 Clinical medicine
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
The role of clonal hematopoiesis of indeterminate potential as a potential driver of cardiovascular diseases and its association with clinical outcome
Trušinskis, K. (Project leader), Vilne, B. (Leading expert), Gailīte, L. (Expert), Rots, D. (Expert), Vīksne, K. (Expert), Kanašniece, E. (Expert (PhD student)), Griķe, I. (Expert (PhD student)) & Uzars, A. (Expert (PhD student))
3/01/22 → 30/12/25
Project: Fundamental and Applied Research Programme
-
State research project in the field of biomedicine, medical technologies and pharmacy
Lejnieks, A. (Partner's coordinator), Karelis, G. (Leading expert), Gardovska, D. (Leading expert), Ābola, Z. (Leading expert), Miklaševičs, E. (Leading expert), Daneberga, Z. (Leading expert), Gardovskis, J. (Leading expert), Pētersons, A. (Leading expert), Kļaviņš, K. (Expert), Kroiča, J. (Leading expert), Skadiņš, I. (Leading expert), Vīksna, L. (Leading expert), Dimiņa, E. (Expert), Sniedze, D. (Participant), Karlsons, J. (Participant), Broks, R. (Participant), Gravele, D. (Expert), Rozentālberga, A. (Expert), Kanašniece, E. (Expert), Konrāde, I. (Leading expert), Trušinskis, K. (Leading expert), Strēle, I. (Leading expert), Kaļiņins, A. (Expert), Ķīvīte-Urtāne, A. (Leading expert), Radziņš, O. (Expert), Bāgante, I. (Leading expert), Koļesova, O. (Leading expert), Nora-Krūkle, Z. (Leading expert), Koļesovs, A. (Expert), Mičule, M. (Participant), Grāvelsiņa, S. (Expert), Rasa-Dzelzkalēja, S. (Leading expert), Kande, L. (Expert), Nakazawa (Miklasevica), M. (Leading expert), Vjaters, E. (Leading expert), Lietuvietis, V. (Leading expert), Plonis, J. (Leading expert), Bitiņa-Barlote, Ē. (Expert), Ieviņa, L. (Participant), Fortūna, K. (Expert (PhD student)), Pētersons, A. (Participant), Pastare, D. (Expert), Pugovičs, O. (Project leader), Silina, S. (Participant), Zemčugova-Bērziņa, A. (Participant), Tihomirova, Ļ. (Participant), Maļina, L. (Participant) & Kozačenko, J. (Participant)
1/12/22 → 30/11/24
Project: National Research Programme
-
The Role of Genetic Variations, MicroRNA Expression and Impaired Carbohydrate Metabolism in Early Atherosclerosis Development and Comparative Effectiveness of Different Lipid Lowering Drug Therapies in the Prevention of Disease Progression
Trušinskis, K. (Project leader), Isakova, J. (Participant) & Kanašniece, E. (Participant)
1/04/19 → 31/03/20
Project: RSU grants
-
Role of Bailout Gene-Silencing Therapy in Plaque Lipid Reduction: Intravascular Imaging Study
Trušinskis, K., Kokina, B. (Corresponding Author), Lapšovs, M., Karantajere, M., Kanašniece, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Grave, A., Kumsars, I. & Erglis, A., 17 Jan 2025, (E-pub ahead of print) In: Cardiology. 20 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
Kokina, B., Trušinskis, K., Lapšovs, M., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Grave, A., Kumsars, I. & Erglis, A., 28 Oct 2024, In: European Heart Journal. 45, Suppl.1, ehae6661440.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
PLAQUE LIPID CONTENT REDUCTION WITH BACKGROUND OF ATORVASTATIN VERSUS ROSUVASTATIN ESCALATED TO GENE-SILENCING THERAPY
Kokina, B., Trušinskis, K., Lapšovs, M., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Kumsars, I. & Erglis, A., 2 Apr 2024, In: Journal of the American College of Cardiology. 83, 13, Suppl., p. 1278Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients
Trusinskis, K., Lapsovs, M., Kokina, B., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Grave, A., Kumsars, I. & Erglis, A., Nov 2023, In: European Heart Journal. 44, Suppl.2, 1 p., ehad655.1313.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
Effects of PCSK9 gene silencing by small interfering RNA inclisiran on coronary atherosclerotic plaque lipid content
Trusinskis, K., Kokina, B., Lapsovs, M., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Kumsars, I. & Erglis, A., Aug 2023, In: Atherosclerosis. 379, Suppl.1, p. S58 SS162.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access